General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity    
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

Insight and the Clinical Outcome of Schizophrenic Patients.

 

McEvoy JP, Freter S, Everett G, Geller JL, Appelbaum PS, Apperson LJ & Roth L. (1989).

Journal of Nervous and Mental Disease, 177(1): 48-51.

RELEVANCE FOR EARLY INTERVENTION

Patients with schizophrenia were followed from 2 � to 3 � years after discharge from the hospital. Although symptoms of psychosis improved in nearly all of the patients over the course of the initial hospitalization, improvement in insight was seen only in those patients who had voluntarily agreed to being hospitalized. Patients who had been involuntarily committed to the hospital did not show a similar improvement in level of insight into the illness. Furthermore, the low levels of insight persisted throughout the follow up period only in those patients who had been involuntarily admitted to the hospital. Not surprisingly, these same patients were more likely to be involuntarily committed over the course of follow up. The authors conclude that an inability to see oneself as ill seems to be a persistent trait in some patients with schizophrenia and one that leads to involuntary commitment.


general resources | legal resources | medical resources | briefing papers | state activity   
hospital closures | preventable tragedies | press room | search | home

FootnoteImage2.jpg (1088 bytes)
Treatment Advocacy Center

The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products.

Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203
703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website)
[email protected] (general email) | [email protected] (press contact)
[email protected] (webmaster)